SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD Pathway)

SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD Pathway)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-79806 1 ml (2 x 500 µl) - -

3 - 15 business days*

1,281.00€
 
The SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD signaling pathway) are replication... more
Product information "SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD Pathway)"
The SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD signaling pathway) are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by multimerized SBE-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the TGFbeta/SMAD signaling pathway can be monitored by measuring the luciferase activity.
Keywords: SBE reporter, TGFbeta reporter, TGFbeta reporter, SMAD reporter,
Supplier: BPS Bioscience
Supplier-Nr: 79806

Properties

Application: TGFbeta/SMAD signaling pathway activator / inhibitor screening, stable cell line generation
Species reactivity: human

Handling & Safety

Storage: -80°C
Shipping: -80°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD Pathway)"
Write a review
or to review a product.
Viewed